期刊文献+

腺病毒载体在小鼠肝脏的分布及其表达规律研究 被引量:2

Distribution and expression of adenovirus vector in mice with MHV-3-induced fulminant hepatitis
下载PDF
导出
摘要 目的研究腺病毒载体介导的β-半乳糖苷酶(LacZ)报告基因在小鼠肝脏的分布及表达情况,评价腺病毒载体作为基因治疗转导系统的有效性及安全性,为进一步的目的基因导入及表达奠定基础。方法将Balb/cJ小鼠随机分为正常组及暴发性肝炎组,给小鼠经尾静脉注射2×108PFU腺病毒,收集24h、48h、72h、96h、120h和第7天小鼠血清,检测谷丙转氨酶和总胆红素,同时取肝脏、肺脏、心脏、肾脏标本进行X-gal染色,以观察腺病毒载体在各脏器的表达情况。取MHV-3诱导的暴发性肝炎组小鼠24h、48h、72h、96h肝脏,检测腺病毒载体在肝脏的表达情况。结果腺病毒载体主要在小鼠肝脏表达,并于72小时表达最高,在正常小鼠及暴发性肝炎小鼠肝脏中表达效率分别约55.7%和25.7%,之后逐渐消减;正常组小鼠注射腺病毒载体后,肝功能无明显变化。结论腺病毒载体介导的报告基因可在肝脏高效表达且未见明显的肝损害,可作为基因治疗中安全有效的基因传递系统用于治疗肝脏疾病。 Objective To study the distribution and expression of β-galactosidase (LacZ) reporter gene mediated by adenovirus vector in the liver of normal mice or mice with fulminant hepatitis, so as to evaluate the efficacy and safety of adenovirus as a gene therapy vector transduction system. Methods The normal Balb/cJ mice were randomly assigned to normal and fulminant hepatitis group. Each mouse was injected with adenovirus at 2×10^8PFU by tail vein injection,then the normal mice serum was collected to detect ALT and TBil at 24h,48h, 72h,96h,120h, and the seventh day,meanwhile,the mice organs including liver,lung,heart,and kidney were collected and stained by X-gal in order to observe the expression of adenovirus vector in mice organ;the expression of adenovirus vector in liver of fulminant hepatitis mice induced by MHV-3 was detected. Results Adenovirus mainly expressed in the livers of mice;In normal group and fulminant hepatitis group,the highest expression efficiency was at 72 hours,reached 55.7% and 25.7%,respectively,then it followed by a gradual reduction of adenovirus expression; The adenovirus infection didn't show obvious injury in liver function. Conclusions The adenovirus vector is highly expressed in the liver with no significantly liver damage; Adenovirus vector might be as an effective and safe gene delivery system for liver disease gene therapy.
出处 《实用肝脏病杂志》 CAS 2012年第3期216-219,共4页 Journal of Practical Hepatology
基金 国家973项目(2007CB512900) 国家自然科学基金项目(30700702) "十一五"国家科技支撑计划项目(2006BAI05A07)
关键词 暴发性肝炎 腺病毒载体 柯萨奇/腺病毒受体 基因治疗 fulminant hepatitis Adenovirus vector Coxsackie/adenovirus receptor Gene therapy
  • 相关文献

参考文献17

  • 1Anderson WF. Human gene therapy. Science,1992,256(5058): 808-813.
  • 2Castell JV,Hernandez D, Gomez-Foix AM, et al. Adenovirus- mediated gene transfer into human hepatocytes:analysis of thebiochemical functionality of transduced cells. Gene Ther, 1997,4 ( 5 ):455-464.
  • 3Zhu C,Sun Y,Luo X,et al. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther,2006,17(6):589-600.
  • 4Edelstein ML,Abedi MR,Wixon J. Gene therapy clinical trims worldwide 1989-2004-an overview. J Gene Med,2004,6(6): 597-602.
  • 5曹明媚,戚中田.基因治疗载体的研究进展[J].国外医学(肿瘤学分册),2004,31(1):22-26. 被引量:12
  • 6Seth P. Adenoviral vectors. Adv Exp Med Biol,2000,465:13- 22.
  • 7Rosenfeld MA,Yoshimura K,Trapnell BC,et al. In vivo trans- fer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell, 1992,68(1):143- 155.
  • 8Zabner J,Couture LA,Gregory RJ,et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Ce11,1993,75 (2):207-216.
  • 9Stratford-Perricaudet LD,Levrero M,Chasse JF,et al. Evalua- tion of the transfer and expression in mice of an enzyme-en- coding gene using a human adenovirus vector. Hum Gene Ther, 1990,1 ( 3 ):241-256.
  • 10Haffe HA, Danel C, Longenecker G, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet, 1992,1(5) :372-378.

二级参考文献30

  • 1Parveen Z, Krupetsky A, Engelstadter M, et al. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat Biotechnol. 2000, 18(6): 623-629.
  • 2Steidl S, Stitz J, Schmitt I, et al. Coreceptot Switch of [ MLV(SIVagm)] pseudotype vectors by V3-loop exchange. Virology,2002, 300(2): 205-216.
  • 3Schiedner G, Morral N, Parks R J, et al. Genomic DNA transfer with a high-capacity adenovius vector results in improved in vivo gene expression and decreased toxicity. Nat Genet, 1998, 18(2) :180-183.
  • 4Sandig V, Youil R, Bett AJ, et al. Optimization of the helper-dependent adenovirus system for production and potency in vlvo. Proc Natl Acad Sci USA, 2000, 97(3): 1002-1007.
  • 5Schoggins JW, Gall JG, Falck-Pedersen E. Subgroup B and f fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J Virol, 2003, 77(2) : 1039-1048.
  • 6Ichrikawa T. Chiocca EA. Comparative analysis of transgene delivery and expression in tumors inoculated with a replication-conditional or-defective viral vector. Cancer Res, 2001, 61(14): 5336-5339.
  • 7Asfour B, Baba HA, Scheld HH, et al. Uniform long-term gene expression using adeno-associated virus (AAV) by ex vivo recirculation in rat-cardiac isografts. Thorac Cardiovasc Surg, 2002, 50 ( 6 ) :347-350.
  • 8Nicklin SA, Baker AFI. Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr Gene Ther, 2002, 2(3) : 273-293.
  • 9Ponnazhagan S, Mahendra G, Kumar S, et al. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol, 2002, 76(24) : 12900-12907.
  • 10Indraccolo S, Habeler W, Tisato V, et al. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.Cancer Res, 2002, 62(21): 6099-6107.

共引文献11

同被引文献24

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部